Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Country's Decision or any other Communication
(DEC)
last updated: 15 Jan 2014
No
Commercial release of Genetically Modified Organism Called Poulvac ST - a live vaccine against Salmonella typhimurium
EN
17 Nov 2010
No
- Decision on LMOs for intentional introduction into the environment (according to Article 10 or domestic regulatory framework)
No
Yes
-
Person:Dr Matusalem Pereira SantosPresident Of CIBio, Zoetis Indústria de Produtos Veterinários LtdaRua Luis Fernando Rodriguez, 1701 Vila Boa VistaCampinas, São Paulo
13064798,Phone: +55 19 37456240,Fax: +55 19 37456189,Email: elianaaguiar@cdn.com.br,Website: http://www.zoetis.com.br/index.br,Related OrganizationFort Dodge Saúde Animal ()Private sector (business and industry)Rua Luis Fernando Rodriguez, 1701 Vila Boa VistaCampinas, São Paulo
13064798,Phone: +55 19 37456240,Fax: +55 19 37456189,Email: elianaaguiar@cdn.com.br,Website: http://www.zoetis.com.br/index.br,
No
Yes
No
Approval of the import and/or use of the LMO(s) without conditions
-
BCH-LMO-SCBD-105185-1 Living Modified Organism Poulvac® ST vaccineFort Dodge Saúde Animal | Production of medical or pharmaceutical compounds (human or animal) (Vaccines)
-
BCH-RA-BR-105212-1 Risk Assessment generated by a regulatory process Risk assessment of Genetically Modified Organism Called Poulvac ST - a live vaccine against Salmonella typhimuriumPoulvac® ST vaccine | SALTM, Production of medical or pharmaceutical compounds (human or animal)
- National Biosafety Commision [ English ]
